119-S-2693 Family Farmer Impact Perspective

Summary of my view

I support S. 2693 because stronger and more transparent federal purchasing of biobased products can create steadier, U.S.-anchored demand for farm feedstocks without touching the safety nets my family relies on (crop insurance, disaster aid) or triggering tax uncertainty. The bill’s annual procurement ramp, U.S.-made preference, price preferences, and oversight (OFPP verification, GAO review) should nudge real buying rather than slogans. My caution: preferences can raise procurement costs and favor large processors unless implementation protects small suppliers. [1]Congress.gov, Library of Congress — S.2693 - Biobased Market Expansion Act of 2…

What the bill changes (in plain terms)

• Requires agencies to increase biobased‑only contracts or volumes each year and allows USDA to set price preferences for biobased items.
• Prioritizes products made wholly or partly in the United States and cross‑references Buy American Act compliance.
• Mandates training for contracting staff, upgrades federal catalogs to clearly flag eligible biobased items, and requires OFPP to collect/verify agency purchasing data annually.
• Directs GAO to evaluate implementation and data quality within two years. [1]Congress.gov, Library of Congress — S.2693 - Biobased Market Expansion Act of 2…

Context: This builds on the existing BioPreferred program in 7 U.S.C. 8102, which already requires preferences for designated categories, sets reporting expectations, and involves OFPP/GSA in implementation. The bill tightens and expands these levers. [2]Legal Information Institute (Cornell) — 7 U.S.C. § 8102 - Biobased markets prog…

Specific impacts on my operation and community

Lens: steady income beats ideology; survival of family farms matters; weather and global competition are givens.

1. Economic impacts
2. Social impacts
3. Environmental and agronomic impacts
4. Short‑ vs. long‑term effects
5. Unintended consequences

1) Economic impacts

• Demand support (good): Federal buyers already must purchase across 100+ designated biobased categories; clearer targets, price preferences, and catalog flags can lift real orders. That incremental pull for soy oil, corn starch, fibers, and residues helps buffer commodity down‑cycles and diversify revenue for co‑ops and regional processors. [3]USDA BioPreferred Program — USDA BioPreferred - Mandatory Federal Purchasing[4]U.S. General Services Administration — GSA: Sustainable solutions and BioPrefer…
• Market scale signal (good): USDA reports the biobased products sector contributed about $489B to the U.S. economy in 2021; aligning federal spend with U.S. production should channel a slice of that toward rural supply chains. [5]USDA Press Release — USDA outlines bioeconomy vision; cites $489B (2021) biobas…
• Cash‑flow clarity (good): OFPP verification and annual reporting reduce the “paper program” problem and help us plan plantings/forward contracts if agencies truly buy more each year. [2]Legal Information Institute (Cornell) — 7 U.S.C. § 8102 - Biobased markets prog…
• Admin ripple (mixed): FAR 52.223‑2 already makes contractors report biobased purchasing; the bill’s added training and verification should improve compliance but may increase paperwork for small vendors we sell into. [6]Acquisition.gov — FAR 52.223-2 – Reporting of Biobased Products Under Service a…
• No direct hit to safety nets (good): The bill doesn’t change crop insurance, disaster programs, or estate/inheritance taxes—so baseline risk management and succession planning stay intact (critical for family farms).

2) Social impacts

• Rural jobs (good): A stronger domestic bioeconomy supports manufacturing near the farmgate; USDA estimates millions of U.S. jobs tied to biobased products, so procurement that favors U.S.‑made should concentrate benefits locally. [5]USDA Press Release — USDA outlines bioeconomy vision; cites $489B (2021) biobas…[7]USDA Press Release — USDA releases Economic Impact Analysis (2017 data): 4.6M j…
• Small supplier access (mixed): Catalog upgrades and staff training should make it easier for smaller, rural manufacturers to be found and specified; but price preferences could also be captured by larger incumbents unless agencies write size‑inclusive specs. [4]U.S. General Services Administration — GSA: Sustainable solutions and BioPrefer…

3) Environmental and agronomic impacts

• Lower life‑cycle footprint (good): USDA analyses find biobased products can reduce GHG emissions versus petroleum alternatives; stable demand for residue‑ or cover‑crop‑based inputs can reward soil‑building practices. [7]USDA Press Release — USDA releases Economic Impact Analysis (2017 data): 4.6M j…
• Water and rights (neutral): The bill doesn’t alter water rights or allocation rules; any water impact is indirect via cropping choices.

4) Short‑ vs. long‑term effects

• Short term: Modest uptick in agency orders once training and catalog changes take effect; some compliance costs for vendors as reporting/verification tightens. [8]U.S. General Services Administration — SAM.gov – Entity Reporting (BioPreferred…[6]Acquisition.gov — FAR 52.223-2 – Reporting of Biobased Products Under Service a…
• Long term: The bill’s emphasis on U.S. production and GAO/OFPP oversight should sustain demand across administrations, encouraging investment in biomanufacturing capacity closer to our fields. [1]Congress.gov, Library of Congress — S.2693 - Biobased Market Expansion Act of 2…

5) Unintended consequences

• Procurement cost inflation: Price preferences and Buy American tilt could raise agency costs; if budgets are fixed, volumes might not grow as fast as hoped. Statute does allow agencies to decline biobased items if price is unreasonable or they’re not available—so real‑world gains will depend on market readiness. [9]Legal Information Institute (Cornell) — 41 U.S.C. Chapter 83 – Buy American[2]Legal Information Institute (Cornell) — 7 U.S.C. § 8102 - Biobased markets prog…
• Consolidation risk: Larger processors may be best positioned to meet specs and compliance, potentially squeezing smaller suppliers unless agencies actively use small‑business tools (outside the bill’s scope).
• Specification gaps: Some categories still lack commercially viable biobased options at scale; the bill’s data improvements will help, but gaps could slow uptake in certain product lines. [3]USDA BioPreferred Program — USDA BioPreferred - Mandatory Federal Purchasing

Key numbers I care about

Bottom line: my stance

Verdict: Favorable. For a multigenerational farm, steady domestic demand and clearer procurement follow‑through matter more than rhetoric. This bill meaningfully tightens the BioPreferred framework while leaving crop insurance, water rights, and estate taxes untouched. I’ll urge our co‑op and local manufacturers to get their products properly labeled, cataloged, and ready to meet federal specs so any new demand translates into farmgate stability. [2]Legal Information Institute (Cornell) — 7 U.S.C. § 8102 - Biobased markets prog…[4]U.S. General Services Administration — GSA: Sustainable solutions and BioPrefer…

Critical risks and implementation checkpoints